Jose, Arathy, Guest, Daniel, LeGay, Remi, Tizzard, Graham J, Coles, Simon J, Derveni, Mariliza, Wright, Edward, Marrison, Lester, Lee, Alpha A, Morris, Aaron, Robinson, Matt, Delft, Frank, Fearon, Daren, Koekemoer, Lizbé, Matviuk, Tetiana, Aimon, Anthony, Schofield, Christopher J, Malla, Tika R, London, Nir, Greenland, Barnaby W, Bagley, Mark C, Spencer, John and The Covid Moonshot Consortium, (2022) Expanding the repertoire of low‐molecular‐weight pentafluorosulfanyl‐substituted scaffolds. ChemMedChem. a202100641 1-12. ISSN 1860-7179

PDF - Published Version Available under License Creative Commons Attribution. Download (5MB)

Abstract

The pentafluorosulfanyl (-SF5) functional group is of increasing interest as a bioisostere in medicinal chemistry. A library of SF5-containing compounds, including amide, isoxazole, and oxindole derivatives, was synthesised using a range of solution-based and solventless methods, including microwave and ball-mill techniques. The library was tested against targets including human dihydroorotate dehydrogenase (HDHODH). A subsequent focused approach led to synthesis of analogues of the clinically used disease modifying anti-rheumatic drugs (DMARDs), Teriflunomide and Leflunomide, considered for potential COVID-19 use, where SF5 bioisostere deployment led to improved inhibition of HDHODH compared with the parent drugs. The results demonstrate the utility of the SF5 group in medicinal chemistry.

Item Type:	Article
Schools and Departments:	School of Life Sciences > Chemistry
SWORD Depositor:	Mx Elements Account
Depositing User:	Mx Elements Account
Date Deposited:	23 Feb 2022 08:54
Last Modified:	23 Feb 2022 10:28
URI:	http://sro.sussex.ac.uk/id/eprint/104514

View download statistics for this item

📧 Request an update